Amphastar Pharmaceuticals

Connections 1

Description

Amphastar Pharmaceuticals is a publicly traded American speciality pharmaceutical company. It was incorporated in May 2004 and primarily develops, manufactures, and sells inhalation and intranasal products.

One of its products is naloxone, an injectable generic drug that treats opioid overdose, and the company was criticized when it doubled the price of the drug from around $20 to $40 in 2015 during the opioid epidemic. In February 2017, the FDA rejected the company's application to market a device that delivers naloxone intranasally.

In March 2018, the company won a patent infringement lawsuit brought against it by Momenta Pharmaceuticals and Sandoz Inc in an ongoing antitrust case.

Website

https://www.amphastar.com

Rating GlobalNY.biz

Take place №1485 In rating New York Organizations general
Take place №117 In rating Healthcare area

7 March 2022

Business

US market this week: company reports, US inflation data

Report timetable The S&P 500, Nasdaq Composite and Dow Jones indices ended Friday's trading dow...

MELVIN Craig

So glad that Savannah’s back in Studio 1A

SPRAYBERRY Dylan

I am a Scientologist. I’ve been a Scientologist for three years now. It’s been an epic experience for me

MCGREGOR Conor

I will overcome this. I will not be deterred

HADDISH Tiffany

I had the best time this week. I made some new friends. I told some jokes that pissed off the White House. And now I can go back to making the president mad just by being a successful Black woman